NCT01758614View on ClinicalTrials.gov

The Carotid and Middle Cerebral Artery Occlusion Surgery Study

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

June 6, 2013

Primary Completion Date

March 2, 2018

Study Completion Date

March 1, 2020

Conditions
Carotid Artery OcclusionMiddle Cerebral Artery OcclusionStroke
Interventions
PROCEDURE

bypass surgery

all participants in this group will be performed EC-IC bypass surgery

DRUG

Aspirin

all participants in this group will be given medical therapy including Aspirin 100mg per day or clopidogrel 75mg per day

DRUG

Clopidogrel

Trial Locations (1)

100053

Department of neurosurgery, Xuanwu hospital, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT01758614 - The Carotid and Middle Cerebral Artery Occlusion Surgery Study | Biotech Hunter | Biotech Hunter